Guideline Title
Infliximab (review) and adalimumab for the treatment of Crohn's disease.
Bibliographic Source(s)
National Institute for Health and Clinical Excellence (NICE). Infliximab (review) and adalimumab for the treatment of Crohn's disease. London (UK): National Institute for Health and Clinical Excellence (NICE); 2010 May. 43 p. (Technology appraisal guidance; no. 187).
Guideline Status
This is the current release of the guideline.
full-text:
National Guideline Clearinghouse | Infliximab (review) and adalimumab for the treatment of Crohn's disease.
No hay comentarios:
Publicar un comentario